Certara conducted in-depth interviews with ten US commercial and Medicare payers.

Certara CS Expansion of Dermatology

From a portfolio view, Certara helped our client guide and accelerate their clinical development by assessing and prioritizing value drivers across efficacy, safety, dosing, and cost parameters.  This enabled them to bring forward a stronger product concept, reducing investment and time to market.

After conducting and analyzing the interviews, Certara;

  • Identified efficacy / safety endpoints and additional economic data that would drive value to payers
  • Provided a comprehensive assessment of each product concept by payers
  • Defined a price range for each product concept and expected formulary access
  • Assessed payers’ future priorities in managing and funding treatments for patients in this therapeutic category and identified how this will affect access to the products tested
  • Identified products to prioritize based on payer assessment
Certara CS Expansion of Dermatology 2

How Can We Help?

Back to top